钆特酸葡甲胺注射液药品报告提供了钆特酸葡甲胺注射液的各种信息,包括钆特酸葡甲胺注射液的药品简介,新药研发进度,仿制药申报进度,中国药品注册情况,一致性评价进度,药品临床试验进度,药品上市等信息.更多药物报告的查询就在戊戌数据药物报告数据库.
戊戌数据药品标准数据库提供了Gadoterate Meglumine Injection钆特酸葡甲胺注射液美国药典标准的查询检索,包括Gadoterate Meglumine Injection钆特酸葡甲胺注射液美国药典的版本USP-NF 2023页码,以及药典的查询与下载.
Anzalone N, Scarabino T, Venturi C, et al. Cerebral neoplastic enhancing lesions: multicenter, randomized, crossover intraindividual comparison between gadobutrol (1.0M) and gadoterate meglumine (0.5M) at 0.1 mmol Gd/kg body weight in a clinical setting. Eur J Radiol 2013;82:139 –45. Saake...
Life-threatening anaphylactoid reaction after iv injection of gadoterate meglumine. MEULI A. & MAEDER P.: Life-threatening anaphylactoid re- action after iv injection of gadoterate meglumine. AJR 166 (1996), 729... RA Meuli,P Maeder - 《Ajr American Journal of Roentgenology》 被引量: 34发表:...
The four gadolinium chelates currently available worldwide, gadopentetate dimeglumine, gadoteridol, gadodiamide, and gadoterate meglumine, cannot be differentiated on the basis of adverse reactions. Far fewer patients have been examined to date with the two other agents that have widespread approval, ...
MEULI A. & MAEDER P.: Life-threatening anaphylactoid re- action after iv injection of gadoterate meglumine. AJR 166 (1996), 729.Meuli RA, Maeder P. Life-threatening anaphylac- toid reaction after IV injection of gadoterate meglu- mine. (letter) AJR 1996; 166:729...
gadolinium that stays in the body is different for different gadolinium medicines. Gadolinium stays in the body more after gadodiamide than after gadoxetate disodium or gadobenate dimeglumine. Gadolinium stays in the body the least after, gadoterate meglumine, gadobutrol, gadoteridol, and gadopiclen...
Twitter LinkedIn Facebook Email Print MORE ON THIS TOPIC Job Trends Life Sciences R&D, Manufacturing Talent Becoming More Difficult to Find: Report June 6, 2024 · 3 min read · Greg Slabodkin BioMidwest Top 5 Companies Hiring in Illinois ...
Life-threatening anaphylactoid reaction after iv injection of gadoterate meglumine. 来自 NCBI 喜欢 0 阅读量: 34 作者: RA Meuli,P Maeder 展开 摘要: Meuli RA, Maeder P. 展开 关键词: brain, diseases demyelinating disease immune deficiency DOI: 10.2214/ajr.166.3.8623674 被引量: 34 ...
The four gadolinium chelates currently available worldwide, gadopentetate dimeglumine, gadoteridol, gadodiamide, and gadoterate meglumine, cannot be differentiated on the basis of adverse reactions. Far fewer patients have been examined to date with the two other agents that have widespread approval, ...